Phentermine
- Generic Name
- Phentermine
- Brand Names
- Adipex-P, Lomaira, Qsymia
- Drug Type
- Small Molecule
- Chemical Formula
- C10H15N
- CAS Number
- 122-09-8
- Unique Ingredient Identifier
- C045TQL4WP
- Background
Phentermine is a sympathomimetic amine anorectic agent and it was introduced in 1959 as part of an anti-obesity combination drug. It is chemically related to amphetamine and it is commonly referred to as an atypical amphetamine. Phentermine has not been reported an addictive potential which allows this agent to be classified under the Schedule IV drugs (low ...
- Indication
Phentermine is indicated, alone or in combination with topiramate, as a short-term adjunct, not pass a few weeks, in a regimen of weight reduction based on exercise, behavioral modifications and caloric restriction in the management of exogenous obesity for patients with an initial body mass index (BMI) greater than 30 kg/m2 or greater than 27 kg/m2 in prese...
- Associated Conditions
- Obesity
- Associated Therapies
- Chronic Weight Management therapy
Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery
- First Posted Date
- 2023-08-04
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 120
- Registration Number
- NCT05975580
- Locations
- 🇺🇸
University of California Irvine Medical Center, Orange, California, United States
Anti-obesity Pharmacotherapy and Inflammation
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2024-05-23
- Target Recruit Count
- 24
- Registration Number
- NCT05756764
- Locations
- 🇺🇸
Ochsner Health System - Biospecimen, New Orleans, Louisiana, United States
🇺🇸LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO, New Orleans, Louisiana, United States
A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects
- First Posted Date
- 2022-01-31
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- VIVUS LLC
- Target Recruit Count
- 565
- Registration Number
- NCT05215418
- Locations
- 🇺🇸
Clinical Site, Norfolk, Virginia, United States
🇺🇸Clinical site, Salt Lake City, Utah, United States
Medications After Adolescent Bariatric Surgery
- First Posted Date
- 2020-10-01
- Last Posted Date
- 2022-05-26
- Lead Sponsor
- Janey Pratt
- Registration Number
- NCT04572217
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds
- First Posted Date
- 2019-09-19
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- Jaime Moore, MD MPH
- Target Recruit Count
- 13
- Registration Number
- NCT04095104
- Locations
- 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery
- Conditions
- Interventions
- First Posted Date
- 2019-02-21
- Last Posted Date
- 2020-07-29
- Lead Sponsor
- Hospital Juarez de Mexico
- Target Recruit Count
- 92
- Registration Number
- NCT03849729
- Locations
- 🇲🇽
Hospital Juárez de México, Ciudad de México, Cdmx, Mexico
Individualized Obesity Pharmacotherapy
- Conditions
- Interventions
- First Posted Date
- 2017-12-15
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 193
- Registration Number
- NCT03374956
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users
- Conditions
- Interventions
- First Posted Date
- 2017-05-12
- Last Posted Date
- 2017-11-13
- Lead Sponsor
- Bioprojet
- Target Recruit Count
- 43
- Registration Number
- NCT03152123
- Locations
- 🇨🇦
INC Research, Toronto, Ontario, Canada
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
- Conditions
- Interventions
- First Posted Date
- 2014-09-17
- Last Posted Date
- 2016-10-06
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 335
- Registration Number
- NCT02243202
Topiramate-Phentermine Combinations for Cocaine Dependence
- Conditions
- Interventions
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2019-11-27
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 38
- Registration Number
- NCT02239913
- Locations
- 🇺🇸
University of Kentucky Medical Center, Lexington, Kentucky, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.